Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT05948657

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

Led by Weill Medical College of Cornell University · Updated on 2026-05-04

200

Participants Needed

4

Research Sites

248 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.

CONDITIONS

Official Title

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male aged 18 years or older
  • Histologically confirmed low or favorable intermediate risk prostate cancer per NCCN guidelines (Grade Group 2 must have 20% or less involvement in each core and no cribiform or intraductal carcinoma)
  • PSA less than 20 ng/ml
  • Ability to undergo yearly PSMA-PET CT
  • Ability to undergo yearly prostate multiparametric MRI
  • Ability to undergo transrectal or transperineal template and fusion prostate biopsy
  • Willingness to have yearly prostate biopsies
Not Eligible

You will not qualify if you...

  • Prior treatment for prostate cancer
  • Prior systemic therapy for prostate cancer
  • Inability to undergo transrectal ultrasound
  • Life expectancy less than 10 years
  • Not interested in pursuing active surveillance
  • Initial prostate cancer diagnosis more than 15 months ago

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

UCLA

Los Angeles, California, United States, 90005

Not Yet Recruiting

2

UCSF

San Francisco, California, United States, 94143

Not Yet Recruiting

3

Weill Cornell Medicine - New York Presbyterian Hospital

New York, New York, United States, 10065

Actively Recruiting

4

UH Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Actively Recruiting

Loading map...

Research Team

H

Holly Kuczynski

CONTACT

S

Sarah Yuan

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here